This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Drosophila melanogaster has proven to be an effective model system in uncovering both genetic and cellular contributions to human cancer. Many elusive genes and signaling pathways that control oncogenic growth were first identified using flies. In many cases, these discoveries were not driven by a direct search for novel genes involved in cancer but rather stemmed from research programs to uncover mechanisms that control growth and development. However, the bounty of genetic tools and the shared evolution of multicellular organisms places Drosophila in a powerful position to purposefully elucidate observations seen in human cancers. In the past decade, the role of antioxidants in cancer progression has shifted dramatically. This review highlights major findings driving this change in perspective and underscores an array of existing work and resources in laboratories using Drosophila that can make significant contributions to how the redox environment affects cancer progression.
Footnotes
Mol Cancer Res 2021;19:38–41
- Received February 26, 2020.
- Revision received July 24, 2020.
- Accepted August 27, 2020.
- Published first September 1, 2020.
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
Volume 19, Issue 1
